Inmedix Inc. Press Releases - EIN Presswire - Press Release Distribution Service

Published on January 23, 2025 - 05:28 GMT

FDA Clears the Inmedix® CloudHRV™ System for Accurate Heart Rate Variability Measurement.

US clinicians now have access to accurate, up-to-date, medical grade heart rate variability (HRV) for clinical care. NORMANDY PARK, WA, UNITED STATES, January 22, 2025 /⁨EINPresswire.com⁩/ -- Inmedix®, Inc. (“Inmedix”) announced today that the US FDA has …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on August 31, 2024 - 00:00 GMT

Inmedix® raises another $38,765.00 to support kids with arthritis at Seattle Children’s

This 8th Annual Golf Tournament takes aggregate funding to over $165,000. NORMANDY PARK, WA, USA, August 30, 2024 /⁨EINPresswire.com⁩/ -- Seattle-based biotech/medtech Inmedix, Inc. continued to support kids with arthritis at its 8th annual Inmedix …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on June 27, 2024 - 15:32 GMT

Inmedix unrestricted educational grant supports UK ‘Stress Matters’ patient advocacy project

National Rheumatoid Arthritis Society (NRAS) explores UK patient concerns connecting stress and rheumatoid arthritis (RA) NORMANDY PARK, WA, USA, June 27, 2024 /⁨EINPresswire.com⁩/ -- Inmedix®, Inc. (“Inmedix”) announced today the publication of a …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on May 30, 2024 - 20:08 GMT

Inmedix completes $4M bridge convertible note round with angel investors to develop and commercialize medical-grade HRV

Proceeds to fund final engineering, cloud processing and US regulatory submission. NORMANDY PARK, WA, USA, May 30, 2024 /⁨EINPresswire.com⁩/ -- Inmedix®, Inc. (“Inmedix”) announced today that it closed its most recent angel funding round on March 31, 2024 …

Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...

Published on January 20, 2024 - 22:18 GMT

Inmedix appoints Lucy Lu as CCO as it approaches US commercialization.

Longstanding commercial medtech and diagnostic experience added to the Inmedix executive team NORMANDY PARK, WA, USA, January 20, 2024 /⁨EINPresswire.com⁩/ -- Seattle-based medtech/biotech Inmedix, Inc., developers of immuno-autonomics and cloud-based …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on January 4, 2024 - 19:41 GMT

Inmedix appoints Nathan Smith as CFO as it approaches US commercialization

Extensive and focused clinical diagnostic CFO experience added to the Inmedix executive team. NORMANDY PARK, WA, USA, January 4, 2024 /⁨EINPresswire.com⁩/ -- Seattle-based medtech/biotech Inmedix, Inc., developers of immuno-autonomics and cloud-based …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on September 28, 2023 - 07:17 GMT

Inmedix® raises another $35,285 to support kids with arthritis at Seattle Children’s Hospital

This 7th Annual Golf Tournament takes the Inmedix total to over $125,000. NORMANDY PARK, WA, USA, September 28, 2023 /⁨EINPresswire.com⁩/ -- Seattle-based biotech/medtech Inmedix, Inc. continued to support kids with arthritis at its 7th annual Inmedix …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on September 14, 2023 - 18:33 GMT

Inmedix welcomes Lee S. Simon, MD, to its Regulatory Advisory Team

Engaging with Dr. Simon to prioritize all aspects of regulatory compliance. NORMANDY PARK, WA, USA, September 14, 2023 /⁨EINPresswire.com⁩/ -- Seattle-based medtech/biotech Inmedix, Inc., developers of immuno-autonomics and cloud-based clinical …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 3, 2023 - 14:32 GMT

Inmedix welcomes Kevin J. Tracey, MD, to its Board of Directors

Dr. Tracey’s research discoveries have been guiding principles for Inmedix since its inception. NORMANDY PARK, WA, USA, May 3, 2023 /⁨EINPresswire.com⁩/ -- Seattle-based medtech/biotech Inmedix, Inc., developers of immuno-autonomics and cloud-based …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on April 4, 2023 - 19:19 GMT

Inmedix® to Present at the 2023 Spring Keiretsu Forum Investor Capital Expo

Inmedix seeks to increase its support among 10 international Keiretsu Forum chapters. NORMANDY PARK, WA, USA, April 4, 2023 /⁨EINPresswire.com⁩/ -- Inmedix®, Inc. is developing CloudHRV™, a proprietary, point-of-service clinical diagnostic on a cloud …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on December 12, 2022 - 23:34 GMT

Inmedix welcomes Leroy Hood MD PhD to its Board of Directors

Exceptional leadership and Board governance expected to expand applications of Inmedix® CloudHRV™ . NORMANDY PARK, WA, USA, December 12, 2022 /⁨EINPresswire.com⁩/ -- Seattle-based medtech/biotech Inmedix, Inc., developers of immuno-autonomics and cloud- …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on September 16, 2022 - 21:40 GMT

Inmedix raises another $19,405 to support kids with arthritis at Seattle Children’s Hospital

6th Annual Inmedix Charity Golf Tournament takes the Inmedix total to nearly $90,000. NORMANDY PARK, WA, USA, September 16, 2022 /⁨EINPresswire.com⁩/ -- Seattle-based biotech/medtech Inmedix, Inc. continued its effort to support kids with arthritis at its …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on September 7, 2022 - 23:21 GMT

Inmedix announces pilot collaboration with the Spaulding Integrative Rehabilitation Laboratory

Leon Morales-Quezada MD, MSc, PhD, MPH to lead investigational research using Inmedix CloudHRV™ NORMANDY PARK, WA, USA, September 7, 2022 /⁨EINPresswire.com⁩/ -- Seattle-based medtech/biotech Inmedix, Inc., developers of immuno-autonomics and cloud-based …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on July 6, 2022 - 14:48 GMT

Inmedix supports the 2022 OPAL Family Office & Private Wealth Management Forum in Newport, RI as a Platinum Sponsor.

Inmedix CEO to discuss the next blue ocean opportunity in healthcare. NORMANDY PARK, WA, USA, July 6, 2022 /⁨EINPresswire.com⁩/ -- Seattle-based medtech/biotech Inmedix, Inc., developers of immuno-autonomics and cloud-based clinical diagnostics to …

Distribution channels: Business & Economy, Conferences & Trade Fairs ...

Published on June 7, 2022 - 16:28 GMT

Seattle MedTech Inmedix announces its 6th Annual Charity Golf Tournament to Support Kids with Arthritis

Aiming to donate over $100K to Seattle Children’s Hospital Pediatric Rheumatology NORMANDY PARK, WA, USA, June 7, 2022 /⁨EINPresswire.com⁩/ -- Seattle-based Inmedix continues its effort to support kids with arthritis with its 6th annual Inmedix Charity …

Distribution channels: Business & Economy, Companies ...

Published on April 21, 2022 - 23:02 GMT

Inmedix returns to the Life Science Innovation Northwest Conference in 2022

Immuno-autonomics gains traction as an innovative strategy improve treatment success in autoimmune diseases. NORMANDY PARK, WA, USA, April 21, 2022 /⁨EINPresswire.com⁩/ -- Seattle-based medtech/biotech Inmedix, Inc. was selected to present at the 2022 …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on April 1, 2022 - 04:40 GMT

Inmedix supports a leading UK charity for rheumatoid arthritis, NRAS, to develop ‘Stress Matters’ resources

Independent educational grant to explore stress impact from the patient’s perspective NORMANDY PARK, WA, USA, March 31, 2022 /⁨EINPresswire.com⁩/ -- Inmedix, Inc., and its subsidiary Inmedix UK, Ltd., developers of immuno-autonomics and cloud-based …

Distribution channels: Business & Economy, Education ...

Published on March 3, 2022 - 07:36 GMT

Inmedix selected as a 2022 FiReStarter Company by Future in Review

Immuno-autonomics gains a spotlight NORMANDY PARK, WA, USA, March 2, 2022 /⁨EINPresswire.com⁩/ -- Inmedix, developers of immuno-autonomics and cloud-based clinical diagnostics quantifying stress biology, was honored by its selection as a 2022 FiReStarter …

Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...

Published on December 7, 2021 - 14:16 GMT

One more time! Again, Inmedix is voted “A most Valued Company” at another 2021 Keiretsu Forum Investor Expo

East coast angel investors select their most promising companies. NORMANDY PARK, WA, USA, December 7, 2021 /⁨EINPresswire.com⁩/ -- Inmedix, Inc., developers of immuno-autonomics and cloud-based clinical diagnostics quantifying stress, was recognized as a …

Distribution channels: Business & Economy, Companies ...

Published on November 12, 2021 - 08:06 GMT

Inmedix Recognized as a ‘Most Valued Company’ at 2021 Keiretsu Forum West Coast Investor Capital Expo

Voted by hundreds of attending angel investors as a stand-out innovator amongst highly touted, growth-stage entrepreneurial companies from U.S. and Canada NORMANDY PARK, WA, USA, November 12, 2021 /⁨EINPresswire.com⁩/ -- Today, Inmedix, Inc., developers …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...